DK1646378T3 - Farmaceutiske præparater omfattende ascorbinsyre til behandling af superinfektion med svamp og recidiv svamp - Google Patents

Farmaceutiske præparater omfattende ascorbinsyre til behandling af superinfektion med svamp og recidiv svamp

Info

Publication number
DK1646378T3
DK1646378T3 DK04739316T DK04739316T DK1646378T3 DK 1646378 T3 DK1646378 T3 DK 1646378T3 DK 04739316 T DK04739316 T DK 04739316T DK 04739316 T DK04739316 T DK 04739316T DK 1646378 T3 DK1646378 T3 DK 1646378T3
Authority
DK
Denmark
Prior art keywords
fungus
superinfection
relapsing
treatment
pharmaceutical compositions
Prior art date
Application number
DK04739316T
Other languages
English (en)
Inventor
Federico Mailland
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polichem Sa filed Critical Polichem Sa
Application granted granted Critical
Publication of DK1646378T3 publication Critical patent/DK1646378T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
DK04739316T 2003-07-22 2004-05-21 Farmaceutiske præparater omfattende ascorbinsyre til behandling af superinfektion med svamp og recidiv svamp DK1646378T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03077314A EP1500394A1 (en) 2003-07-22 2003-07-22 Pharmaceutical compositions comprising ascorbic acid or the treatment of fungal superinfections and fungal recurrences
PCT/EP2004/005559 WO2005013971A1 (en) 2003-07-22 2004-05-21 Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences

Publications (1)

Publication Number Publication Date
DK1646378T3 true DK1646378T3 (da) 2009-01-19

Family

ID=33483977

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04739316T DK1646378T3 (da) 2003-07-22 2004-05-21 Farmaceutiske præparater omfattende ascorbinsyre til behandling af superinfektion med svamp og recidiv svamp

Country Status (22)

Country Link
US (1) US7863326B2 (da)
EP (2) EP1500394A1 (da)
JP (1) JP4791358B2 (da)
KR (1) KR101100713B1 (da)
CN (1) CN100540000C (da)
AR (1) AR045070A1 (da)
AT (1) ATE413171T1 (da)
BR (1) BRPI0412453A (da)
CA (1) CA2528879A1 (da)
CY (1) CY1108684T1 (da)
DE (1) DE602004017613D1 (da)
DK (1) DK1646378T3 (da)
EA (1) EA010241B1 (da)
ES (1) ES2314406T3 (da)
HR (1) HRP20090022T3 (da)
MX (1) MXPA05013798A (da)
PL (1) PL1646378T3 (da)
PT (1) PT1646378E (da)
SI (1) SI1646378T1 (da)
UA (1) UA88446C2 (da)
WO (1) WO2005013971A1 (da)
ZA (1) ZA200509851B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007000662A2 (en) * 2005-02-03 2007-01-04 Taro Pharmaceuticals U.S.A., Inc. Novel propofol composition comprising ascorbic acid or pharmaceutically acceptable salts thereof
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
US20090197946A1 (en) * 2008-01-31 2009-08-06 Joseph Di Bartolomeo Composition and method for treatment of inflamation and infections of the genitalia, contraceptive and the prophylaxis of sexually transmitted diseases
FI20095550A0 (fi) * 2009-05-19 2009-05-19 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
ES2477141B2 (es) * 2010-04-08 2015-02-23 University Of Florida Research Foundation, Inc. Sistema basado en un vector viral de expresión transitoria que permite múltiples aplicaciones
US12612370B2 (en) 2011-03-02 2026-04-28 Thermolife International, Llc Amino acid compositions
DE102012009057A1 (de) 2012-05-09 2013-11-14 Dr. Arabin GmbH & Co. KG Rotationspessar mit zusätzlicher Wirkstoffkomponente
FR3018193B1 (fr) * 2014-03-10 2017-09-08 Probionov Comprime vaginal muco-adhesif a liberation prolongee
AU2021377897A1 (en) 2020-11-12 2024-09-12 Thermolife International, Llc Methods of increasing blood oxygen saturation
US11865139B2 (en) * 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches
KR20230145103A (ko) 2021-02-11 2023-10-17 써모라이프 인터내셔널, 엘엘씨 산화질소 기체의 투여 방법
WO2025245573A1 (en) * 2024-05-28 2025-12-04 Liquim Limited Formulation and hydrogels formed therefrom
CN120600339B (zh) * 2025-08-05 2025-09-30 中国人民解放军空军军医大学 一种抗真菌药物肝毒性检测方法及系统

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4229430A (en) * 1978-08-21 1980-10-21 Fahim Mostafa S Oral composition for improving oral health
JPH01125306A (ja) * 1987-11-09 1989-05-17 Daiichi Seimo Kk 赤腐れ菌の防除剤
EP0527241B1 (de) * 1991-07-15 1994-03-16 Artesan Pharma Gesellschaft mit beschränkter Haftung Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich
US5425944A (en) * 1992-10-27 1995-06-20 Harich; Jakob Antimicrobial grapefruit extract
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
CN1245074A (zh) * 1998-04-26 2000-02-23 曾忠铭 减弱阴道酸度的药剂和用途
US6153635A (en) * 1998-11-20 2000-11-28 Upmalis; David H. Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate
JP2000169370A (ja) * 1998-12-09 2000-06-20 Frontier:Kk 肉食動物用皮膚疾患治療薬及び健康食品
DE29900513U1 (de) * 1999-01-14 2000-08-10 RST Icking GmbH, 82057 Icking Schuh- bzw. Fuß-Hygienemittel
RU2150935C1 (ru) * 1999-06-22 2000-06-20 Московский государственный медико-стоматологический университет Защитно-профилактический крем
US6391330B1 (en) * 2000-05-11 2002-05-21 Michael A. Ross Proanthocyanidins and ascorbic acid composition for topical application to human respiratory and oral mucosa
US20030130225A1 (en) * 2001-10-16 2003-07-10 Nawaz Ahmad Novel methods of treating local fungal and bacterial infections

Also Published As

Publication number Publication date
ATE413171T1 (de) 2008-11-15
BRPI0412453A (pt) 2006-10-17
HRP20090022T3 (hr) 2009-02-28
AR045070A1 (es) 2005-10-12
EA010241B1 (ru) 2008-06-30
US20070037880A1 (en) 2007-02-15
EP1500394A1 (en) 2005-01-26
EP1646378B1 (en) 2008-11-05
DE602004017613D1 (de) 2008-12-18
CN1812781A (zh) 2006-08-02
UA88446C2 (uk) 2009-10-26
US7863326B2 (en) 2011-01-04
PL1646378T3 (pl) 2009-04-30
HK1092693A1 (en) 2007-02-16
KR20060040603A (ko) 2006-05-10
ES2314406T3 (es) 2009-03-16
JP2006528138A (ja) 2006-12-14
CY1108684T1 (el) 2014-04-09
WO2005013971A1 (en) 2005-02-17
JP4791358B2 (ja) 2011-10-12
CN100540000C (zh) 2009-09-16
EP1646378A1 (en) 2006-04-19
KR101100713B1 (ko) 2011-12-30
EA200600176A1 (ru) 2006-06-30
MXPA05013798A (es) 2006-06-27
CA2528879A1 (en) 2005-02-17
PT1646378E (pt) 2008-12-17
ZA200509851B (en) 2007-03-28
SI1646378T1 (sl) 2009-02-28

Similar Documents

Publication Publication Date Title
EP1513825A4 (en) ANTITU-CULINARY MEDICAMENT: COMPOSITIONS AND METHODS
DK1679058T3 (da) Farmaceutisk sammensætning til behandling af kardiovaskulære og cerebrovaskulære sygdomme
DK1853271T3 (da) Fremgangsmåde og præparat til behandling af perifere vaskulære sygdomme
DK1644021T3 (da) Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
DK1487541T3 (da) Anvendelse af IL-18-inhibitorer til behandling og/eller forebyggelse af perifere vaskulære sygdomme
IS7543A (is) Bensóþíadíasepínafleiður, aðferðir til framleiðslu þeirra og lyfjablöndur sem innihalda þær
DK1620429T3 (da) Nye heterocykliske forbindelser anvendelige til behandling af inflammatoriske og allergiske sygdomme, fremgangsmåder til deres fremstilling og farmaceutiske sammensætninger indeholdende disse
NO20044272L (no) Legemiddel for behandling og/eller forebyggelse av kronisk avstotning
PT1605956E (pt) Administração de capsaicinóides para o tratamento da osteoartrite
DK1423381T3 (da) 17beta-hydroxysteroid-dehydrogenase type 3-inhibitorer til behandling af androgenafhængige sygdomme
DK1638589T3 (da) Kombinationsterapi med glatirameracetat og mitoxantron til behandling af multipel sklerose
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
IS8597A (is) Samsetningar rísedrónats og aðferðir við notkun þess
DK1617834T3 (da) Anvendelse af en farmaceutisk sammensætning indeholdende mælkesyre eller lactat og kalium til behandling af hjerneödem eller hjerneskade
DK1635791T3 (da) Farmaceutisk komposition omfattende atorvastatin og fremstillet uden granulering
DE602005005456D1 (de) Neue azabicyclische derivate, herstellungsverfahren dafür und sie enthaltende pharmazeutische zusammensetzungen
EP1562618A4 (en) CYCLOOXYGENASE-2-HEMMENDEWITHANOLID COMPOSITIONS AND METHODS
NO20050569D0 (no) Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette
NO20055173D0 (no) Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel
DK1478438T3 (da) Fremgangsmåder og sammensætninger til behandling af astma
NO20070892L (no) Sammensetninger av N-glykolylneuraminsyre og anvendelse derav ved behandling av forkjølelse.
PL361518A1 (pl) Zastosowanie substancji oraz kompozycja farmaceutyczna
DK1848415T3 (da) Kombinationsterapi med glatirameracetat og rasagilin til behandling af multipel sklerose
DK1589973T4 (da) Formulering og fremgangsmåder til behandling af thrombocytæmi
DK1750713T3 (da) Anvendelse af imatinib til behandling af leversygdomme og vi-rusinfektioner